After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
JAZZ belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Jazz Pharmaceuticals plc is $10.02B. A total of 1.12 million shares were traded on the day, compared to an average of 1.02M shares.
In the most recent transaction, Henderson Mary Elizabeth sold 2,238 shares of JAZZ for 169.51 per share on Dec 09 ’25. After the transaction, the SVP, Technical Operations now owns 19,508 company shares. In a previous transaction on Dec 09 ’25, MARY ELIZABETH HENDERSON bought 2,238 shares at 169.51 per share.
Among the insiders who sold shares, Carr Patricia disposed of 4,660 shares on Dec 05 ’25 at a per-share price of $171.20. This resulted in the SVP, Chief Accounting Officer holding 7,012 shares of JAZZ after the transaction. In another insider transaction, PATRICIA CARR bought 4,660 shares at $171.20 per share on Dec 05 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, JAZZ has a high of $182.99 and a low of $95.49.
As of this writing, JAZZ has an earnings estimate of $6.4 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $6.74 per share and a lower estimate of $5.81. The company reported an EPS of $6.6 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. JAZZ’s latest balance sheet shows that the firm has $591.45M in Cash & Short Term Investments as of fiscal 2021. There were $6.15B in debt and $809.30M in liabilities at the time. Its Book Value Per Share was $65.18, while its Total Shareholder’s Equity was $3.97B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JAZZ is Buy with a score of 4.56.
